GREG H. GARDELLA is a partner in the firm's Post Grant Patent Practice Group focusing on post-grant patent proceedings, patent prosecution, strategic counseling, due diligence investigations, and pre-suit investigations. Mr. Gardella is a former litigator, having spent the first several years of his practice handling high-stakes patent litigation for various Fortune 100 clients. He leverages his extensive litigation background to focus on adversarial post grant USPTO proceedings. A distinguished reexamination specialist, he has handled a significant number of high-stakes patent reexamination disputes such as the noteworthy defense of the famous TiVo time warp patent and serving as lead counsel for St. Jude Medical in its post-grant challenges of Medtronic's renal denervation portfolio.
Mr. Gardella has been named by Intellectual Asset Management as one of the world’s leading patent practitioners. Indeed, he was selected as one of the top attorneys in the country for adversarial post-grant proceedings:
Greg H Gardella is another prominent member of [Oblon Spivak’s] post-grant prosecution group. His former big-ticket patent litigation experience has served him well in contested reexamination proceedings, of which he is regarded a master.
The other honors received by Mr. Gardella can be found at the Accolades tab, above.
Prior to joining Oblon Spivak, Mr. Gardella was a partner at Irell & Manella, LLP. While there he chaired the Reexamination Practice Group and oversaw the training of lawyers and patent agents related to Patent Office proceedings.
Mr. Gardella also develops and manages the patent portfolios of mid-sized and large technology-focused companies. He has extensive experience in strategic enforcement and freedom-to-operate counseling wherein he advises companies how best to enforce their patent portfolios and take defensive measures to circumvent patent assertions by competitors.
Mr. Gardella has substantial education and experience in the following technical areas: semiconductor fabrication and device structure (e.g. vapor deposition, etch, patterning, spin-on coatings, implant, epitaxy, LEDs, power MOSFETs, solar cells, LCDs), computer architecture (e.g. superscalar uPs, graphics/memory controllers, I/O controllers, adapters, bridges, DMA, cache coherency, power management), wireless telecommunications (e.g. GSM, IS-95/54, GPRS and 3G standards, including WCDMA, CDMA-2000, and UMTS; security protocols; vocoding; bridging; duplexing), network data communication (e.g. Bluetooth and other wireless protocols, access control, routing, ATM, enterprise platforms, ASPs, VPNs), software ranging from microcode to application layer (e.g. middleware, OS, SSL, drivers, application layer suites, environments including C, C++, Java, XML, HTML, TEK, Perl, HDLs), medical devices (e.g. implantable devices, surgical devices, automated pharmacy systems, defibrillators, spinal implants, slow release implants, endoscopic devices), signal processing, embedded controllers, VLSI design, microstructured films, and various types of industrial equipment.
Mr. Gardella contributes to the firm’s Patents Post Grant Law Blog, providing insights and commentary on existing and proposed post-grant options, trends, practice tips and news relating to patent reexamination, reissue and the new post grant procedures introduced by the Leahy Smith America Invents Act.